Company profile for Oakrum Pharma, LLC

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Oakrum Pharma, LLC, a St. Louis based corporation, officially formed its U.S. Pharmaceutical business on October 4, 2018 when it received its certificate of registration in the state of Missouri. Oakrum Pharma hired Marco Polizzi, a seasoned brand and generic pharma industry veteran, to lead the formation and development of this new business entity. The launch of Oakrum Pharma is an effort to bring more affordable medicines to...
Oakrum Pharma, LLC, a St. Louis based corporation, officially formed its U.S. Pharmaceutical business on October 4, 2018 when it received its certificate of registration in the state of Missouri. Oakrum Pharma hired Marco Polizzi, a seasoned brand and generic pharma industry veteran, to lead the formation and development of this new business entity. The launch of Oakrum Pharma is an effort to bring more affordable medicines to a patient population that has been underserved due to its small size and unique needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3636 S Geyer Road, Suite 100 St. Louis, Mo. 63127
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20220728005357/en

BUSINESSWIRE
28 Jul 2022

https://www.prnewswire.com/news-releases/oakrum-pharma-and-ani-pharmaceuticals-announce-the-launch-of-betaine-anhydrous-powder-the-first-generic-version-of-cystadane-betaine-anhydrous-for-oral-solution--powder-including-180-days-of-exclusivity-301481968.html

PRNEWSWIRE
14 Feb 2022

https://www.prnewswire.com/news-releases/aucta-pharma-and-oakrum-pharma-announce-launch-of-generic-version-of-jadenur-sprinkle-deferasirox-granules-301310888.html

PRNEWSWIRE
14 Jun 2021

https://www.prnewswire.com/news-releases/oakrum-pharma-and-aucta-pharma-announce-us-fda-approval-of-generic-version-of-jadenu-sprinkle-deferasirox-granules-301252585.html

PRNEWSWIRE
22 Mar 2021

http://www.globenewswire.com/news-release/2020/04/15/2016587/0/en/Oakrum-Pharma-Announces-the-Launch-of-Toxo-Total-Care-Patient-Services-Program-to-Support-Pyrimethamine-25mg-Tablets.html

GLOBENEWSWIRE
15 Apr 2020

https://www.ptcommunity.com/wire/oakrum-pharma-announces-launch-pyrimethamine-25mg-tablets-united-states

PTCOMMUNITY
12 Mar 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty